Association of IL-12p40 +1188 A/C polymorphism with nasopharyngeal cancer risk and tumor extension

Tissue Antigens

Volumn 78, Issue 2, 2011, Pages 148-151

  Ben Chaaben, A ^a,b,c   Busson, M ^b   Douik, H ^a   Boukouaci, W ^b   Mamoghli, T ^a   Chaouch, L ^a   Harzallah, L ^a   Dorra, S ^a   Fortier, C ^b   Ghanem, A ^a   Charron, D ^b   Krishnamoorthy, R ^d   Guemira, F ^a   Tamouza, R ^b  

^a SALAH AZAIEZ INSTITUTE   (Tunisia)

^b INSERM   (France)

^c FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^d HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

IL 12p40 polymorphism; Nasopharyngeal carcinoma; Tunisia

Indexed keywords

INTERLEUKIN 12P40;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RISK; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; SCHOOL CHILD; TUNISIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-12 SUBUNIT P40; MALE; MIDDLE AGED; MODELS, STATISTICAL; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK; SEQUENCE ANALYSIS, DNA; TUNISIA;

EID: 79959919677     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01702.x     Document Type: Article

References (34)

1. Parkin DM, Muir CS. Cancer incidence in five continents. Compatibility and quality of data. IARC Sci Publ 1992: 120: 45-173.
2. Bouchardy C, Parkin DM, Wanner P, Khlat M. Cancer mortality among North African migrants in France, Int J Epidemiol 1996: 25: 5-13.
3. Cammoun M, Hoerner V, Mourali N. Tumor of nasopharynx in Tunisia. An anatomic and clinical study based on 143 cases, Cancer 1974: 33: 184-92.
4. McDerrmott AL, Dutt SN, Watkinson JC. The aetiology of nasopharyngeal carcinoma, Clin Otolaryngol Allied Sci 2001: 26: 82-92.
5. Burgos JS. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Med Oncol 2005: 22: 113-21.
6. Feng BJ, Jalbout M, Ayoub WB et al. Dietary risk factors for nasopharyngeal in Magrebian countries. Int J Cancer 2007: 21: 1550-5.
7. Chan ATC, Teo PML, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol 2002: 13: 1007-15.
8. Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 2002: 12: 451-62.
9. Zhou X, Cui J, Macias V et al. The progress on genetic analysis of nasopharyngeal carcinoma. Comp Funct Genomics 2007: 57513: 1-13.
10. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003: 3: 133-46.
11. Brunda MJ, Luistro L, Warrier RR et al. Antitumor and antimetastasic activity of interleukin 12 against murine tumors. J Exp Med 1993: 178: 1223-30.
12. Sangro B, Melero I, Qian C, Prieto J. Gene therapy of cancer based on interleukin 12. Curr Gene Ther 2005: 6: 573-81.
13. Nanni P, Nicoletti G, De Giovanni C et al. Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neutransgenic mice. J Exp Med 2001: 194: 1195-205.
14. Murakami S, Okubo K, Tsuji Y, Sakata H, Hamada S, Hirayama R. Serum interleukin-12 levels in patients with gastric cancer. Surg Today 2004: 34: 1014-19.
15. Mailliard RB, Son YI, Redlinger R et al. Dentritic cells mediate NK cell help for th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 2003: 171: 2366-73.
16. Huang D, Cancilla MR, Morahan G. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun 2000: 8: 515-20.
17. Hoffmann TW, Halimi JM, Büchler M et al. Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation. Transplantation 2008: 85: 1406-11.
18. Windsor L, Morahan G, Huang D et al. Alleles of the IL12B 3' UTR associate with late onset of type 1 diabetes. Hum Immunol 2004: 65: 1432-36.
19. Zhao B, Meng LQ, Huang HN, Pan Y, Xu QQ. A novel functional polymorphism, 16974 A/C in the interleukin-12-3' untranslated region is associated with risk of Glioma. DNA Cell Biol 2009: 28: 335-41.
20. Stanilova S, Miteva L, Parakova G. Interleukin-12 B-3' UTR polymorphism in association with IL-12 p40 and IL-12 p70 serum levels and silicosis severity. Int J Immunogenet 2007: 34: 193-9.
21. Han SS, Cho EY, Lee TS et al. Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical cancer in Korean women. Eur J Obstet Gynecol Reprod Biol 2008: 140: 71-5.
22. Chen X, Han S, Wang S et al. Interactions of IL-12 A and IL-12 B polymorphisms on the risk of cervical cancer in Chinese women. Clin Cancer Res 2009: 15: 400-5.
23. Kordi Tamandani DM, Shekari M, Suri V. Interleukin-12 gene polymorphism and cervical cancer risk. Am J Clin Oncol 2009 [Epub ahead of print].
24. Wei YS, Lan Y, Luo B, Lu D, Nong HB. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Mol Carcinogen 2009: 48: 751-7.
25. Morahan G, Huang D, Ymer SI et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 2001: 2: 218-21.
26. Seegers D, Zwiers A, Strober W, Peña AS, Bouma G. A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 2002: 7: 419-23.
27. Miteva L, Stanilov N, Deliysky T, Mintchev N, Stanilova S. Association of polymorphisms in regulatory regions of interleukin-12p40 gene and cytokine serum level with colorectal cancer. Cancer Invest 2009: 27: 924-31.
28. Sobin HL, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997), Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997: 80: 1803-4.
29. John SW, Weitzner G, Rozen R, Scriver CR. A rapid procedure for extracting genomic DNA from leukocytes. Nucl Acids Res 1991: 19: 408.
30. Farha K, Hassen E, Bouzgarrou N, Gabbouj S, Bouaouina N, Chouchane L. Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients. Cytokine 2008: 43: 132-7.
31. Ben Nasr H, Chahed K, Mestiri S, Bouaouina N, Snoussi K, Chouchane L. Association of IL-8 (-251) T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma. Hum Immunol 2007: 68: 761-9.
32. Hassen E, Nahla G, Bouaouina N, Chouchane L. The human leukocyte antigen class I genes in nasopharyngeal carcinoma risk. Mol Biol Rep 2010: 37: 119-26.
33. Douik H, Ben Chaaben A, Romthane NA et al. Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population. Hum Immunol 2009: 70: 45-8.
34. Lan Q, Zheng T, Rothman N et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 2006: 107: 4101-8.